Vaccination of Rabbits with a Cholera Conjugate Vaccine Comprising O-Specific Polysaccharide and a Recombinant Fragment of Tetanus Toxin Heavy Chain Induces Protective Immune Responses against Vibrio cholerae O1.

"Disclosure: Animal work was performed in accordance with all governmental and institutional requirements. All rabbit-based work was performed in compliance with the Animal Review Committee of Eurofins Advinus Limited. Murine-based work in Boston was approved by the Massachusetts General Hospital Subcommittee on Research Animal Care (SRAC). E.T.R., J.L., R.G., and P.K. are joint senior authors of this work."

"Financial support: This research was supported through programs funded by the RIGHT Fund (ID: RF-2018-V01; Research in Global Health Technologies), Seoul, South Korea, the Wellcome Trust (reference number 221595/Z/20/Z), and the National Institutes of Health, including the National Institute of Allergy and Infectious Diseases (grant numbers AI106878 [E. T. R. and F. Q.] and AI137164 [R. C. C.]), the Fogarty International Center Training Grant in Vaccine Development and Public Health (grant number TW005572 [M. K. and T. R. B.]), the Emerging Global Fellowship Award (grant number TW010362 [T. R. B.]), and the Intramural Research Program of the NIH and the National Institute of Diabetes and Digestive and Kidney Diseases (P. X. and P. K.)."